Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine oral solution for pediatric chronic spontaneous urticaria
2010-023057-11Phase 3Active
- Sponsor
- Uriach
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rupatadine in chronic idiopathic urticaria (CIU) and chronic urticaria (CU) (3 arms), sponsored by Uriach. Primary endpoint: Primary efficacy endpoint. Started Feb 2011; status: active.
02
Drugs
rupatadine
03
Conditions
chronic idiopathic urticaria (CIU)chronic urticaria (CU)
Beyond the preview
Go deeper on 2010-023057-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023057-11.